COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
Publication
, Conference
Helzberg, J; Henson, JB; Muir, AJ
Published in: HEPATOLOGY
2021
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2021
Volume
74
Start / End Page
753A / 754A
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Helzberg, J., Henson, J. B., & Muir, A. J. (2021). COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS. In HEPATOLOGY (Vol. 74, pp. 753A-754A).
Helzberg, James, Jacqueline B. Henson, and Andrew Joseph Muir. “COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS.” In HEPATOLOGY, 74:753A-754A, 2021.
Helzberg J, Henson JB, Muir AJ. COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS. In: HEPATOLOGY. 2021. p. 753A-754A.
Helzberg, James, et al. “COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS.” HEPATOLOGY, vol. 74, 2021, pp. 753A-754A.
Helzberg J, Henson JB, Muir AJ. COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS. HEPATOLOGY. 2021. p. 753A-754A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2021
Volume
74
Start / End Page
753A / 754A
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics